Founded Year

2013

Stage

Series D | Alive

Total Raised

$610.3M

Last Raised

$372M | 1 yr ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+1 points in the past 30 days

About Formation Bio

Formation Bio focuses on improving drug development within the pharmaceutical industry. The company specializes in acquiring clinical-stage assets and using its proprietary technology platform to enhance the drug development process. Formation Bio serves the pharmaceutical and biotech sectors, working to connect medical research and patient access to new treatments. Formation Bio was formerly known as TrialSpark. It was founded in 2013 and is based in New York, New York.

Headquarters Location

16 East 34th Street Floor 10

New York, New York, 10016,

United States

443-277-1832

Loading...

Loading...

Research containing Formation Bio

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Formation Bio in 4 CB Insights research briefs, most recently on Jan 16, 2025.

Expert Collections containing Formation Bio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Formation Bio is included in 2 Expert Collections, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,276 items

D

Digital Health

11,408 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Latest Formation Bio News

Sanofi licenses gusacitinib from Formation Bio

Jun 24, 2025

24 June 2025 New York-based Formation Bio, an AI-native pharma company focused on accelerating drug development, revealed that its subsidiary Libertas Bio has licensed gusacitinib to Sanofi (Euronext: SAN), expanding the partnership between the companies. Sanofi will explore the dual JAK/SYK inhibitor  potential in a new indication not previously studied through a Phase I study. Formation has taken gusacitinib into Phase III development for chronic hand eczema. The deal could be worth up to 545 million euros ($629.3 million), including upfront and milestone payments, as well as low to mid-teen royalties based on future sales. licensing deal comes about a year after the pair first joined forces. Last May, Formation, along with ChatGPT developer OpenAI, agreed to help Sanofi integrate AI into its drug development workflow, including by creating customised AI agents and models. This article is accessible to registered users, to continue reading please register for free . A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please  login . If your trial has come to an end, you can  subscribe here. Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters. Receive The Pharma Letter daily news bulletin, free forever. Become a subscriber

Formation Bio Frequently Asked Questions (FAQ)

  • When was Formation Bio founded?

    Formation Bio was founded in 2013.

  • Where is Formation Bio's headquarters?

    Formation Bio's headquarters is located at 16 East 34th Street, New York.

  • What is Formation Bio's latest funding round?

    Formation Bio's latest funding round is Series D.

  • How much did Formation Bio raise?

    Formation Bio raised a total of $610.3M.

  • Who are the investors of Formation Bio?

    Investors of Formation Bio include Sequoia Capital, Thrive Capital, Emerson Collective, Lachy Groom, Andreessen Horowitz and 17 more.

  • Who are Formation Bio's competitors?

    Competitors of Formation Bio include Biorce, Castor, Virgo Surgical Video Solutions, ObvioHealth, Inato and 7 more.

Loading...

Compare Formation Bio to Competitors

Castor Logo
Castor

Castor operates within the healthcare sector and provides a clinical trial platform designed for the design, deployment, patient engagement, data collection, and analysis of clinical trials. The platform is adaptable and can meet the requirements of different stakeholders in the clinical research process. It primarily serves the healthcare sector. The company was founded in 2012 and is based in Amsterdam, Netherlands.

Reify Health Logo
Reify Health

Reify Health specializes in optimizing clinical trial operations within the healthcare sector. The company offers cloud-based software solutions designed to accelerate patient enrollment in clinical trials, aiming to streamline the process of bringing new therapies to patients. Reify Health primarily serves the biopharmaceutical industry, research clinics, and healthcare organizations involved in clinical research. Reify Health was formerly known as ZeroSum Health. It was founded in 2012 and is based in Boston, Massachusetts.

Medable Logo
Medable

Medable is a company that offers a cloud-based platform for decentralized clinical trial technology in the healthcare and clinical research sectors. The platform facilitates electronic Clinical Outcome Assessments (eCOA), remote monitoring, and the integration of connected healthcare sensors for clinical trials. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.

ObvioHealth Logo
ObvioHealth

ObvioHealth provides digital health solutions within the clinical trial industry. The company has a platform and mobile application allows for remote monitoring and participation in clinical trials, focusing on data collection and participant engagement. ObvioHealth's services are relevant to the healthcare sector, especially in trial management. It was founded in 2017 and is based in New York, New York.

Bloqcube Logo
Bloqcube

Bloqcube specializes in clinical trial management software within the life science industry. Its platform aggregates data in real-time and aims to assist small and midsize life-science companies. Bloqcube's services are directed towards the life science sector, focusing on clinical trials. It was founded in 2017 and is based in Piscataway, New Jersey.

Lindus Health Logo
Lindus Health

Lindus Health conducts end-to-end clinical trials for the life sciences sector, using a technology-driven approach to streamline the process. The company provides services including study design, patient recruitment, clinical data capture, monitoring, and project management, facilitated by a proprietary software platform and access to electronic health records. It serves the biotechnology and pharmaceutical industries. The company was founded in 2021 and is based in London, United Kingdom.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.